Key result
Acquired long-QT conditions induce arrhythmogenic rotors in ~57% of human engineered heart tissues.
Why the study?
Human iPSC-derived engineered heart tissues are used to model cardiac physiology and drug responses, but whether they reproduce tissue-scale ventricular arrhythmia mechanisms remained unclear.
Does combining hERG blockade with hypokalemia/hypomagnesemia or inducing focal cryoinjury reproduce trigger- and substrate-driven ventricular tachycardia mechanisms in human iPSC-derived engineered heart tissues?
Does combining hERG blockade with hypokalemia/hypomagnesemia or inducing focal cryoinjury reproduce trigger- and substrate-driven ventricular tachycardia mechanisms in human iPSC-derived engineered heart tissues?
This study establishes human iPSC-derived engineered heart tissues paired with dual voltage/Ca2+ optical mapping as a viable non-animal platform capable of reproducing both trigger-driven (aLQTS) and substrate-driven (cryoinjury) mechanisms of ventricular tachycardia.
Human iPSC-EHTs model VT rotors under aLQTS and injury; leaves open clinical translation pending prospective validation.
Human iPSC‑derived engineered heart tissues (EHTs) are used to model cardiac physiology and drug responses, yet whether they reproduce tissue‑scale ventricular arrhythmia mechanisms remains unclear. We combined modified milliPillar EHT fabrication with high‐resolution dual‐channel voltage/Ca 2+ optical mapping. Baseline electrophysiology showed action potential durations (APD) within the range reported for human ventricles and conduction velocities approximately half of human longitudinal values, with rate‑dependent restitution of APD and Ca 2+ transient duration, conduction slowing, and physiologic AP‐Ca 2+ latency. To interrogate a trigger arm of ventricular tachycardia (VT), we modeled acquired long‐QT syndrome (aLQTS; hERG blockade with hypokalemia/hypomagnesemia) in EHTs from two hiPSC lines. aLQTS EHTs developed VT‐like episodes with beat‑to‑beat instability. Early afterdepolarizations propagated heterogeneously, generating triggered activity, tissue acceleration, APD dispersion, wavebreak, and rotor formation. These were short and self‐terminating (median 0.4 s) and clustered at head/neck region curvatures. To test whether a fixed spatial substrate supports prolonged reentry, we developed a reproducible focal cryoinjury model. After injury, all tissues developed VT‐like episodes, and 70% anatomically anchored rotors at the border; three persisted beyond 10 s, a recording‐limited lower bound. Dual voltage/Ca 2+ mapping at this resolution establishes EHTs as a non‐animal platform for mechanistic study of both trigger‐ and substrate‐driven ventricular arrhythmias.
No takes yet. Share an insight, caveat, or question.
Fiedler et al. (2026) studied Ventricular tachycardia and acquired long-QT syndrome in human engineered heart tissues (n=55). Acquired long-QT syndrome condition (E-4031 with hypokalemia and hypomagnesemia) and focal cryoinjury vs. Control standard Tyrode's solution / pre-injury baseline was evaluated on Incidence of phase singularities (rotors) during optical mapping. Human engineered heart tissues exposed to acquired long-QT conditions developed rotors in 57.1% (16/28) vs 0% (0/27) in controls, while focal cryoinjury induced anchored rotors in 70% (7/10).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: